Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

United Therapeutics Corp (NASDAQ:UTHR)

Thursday’s trading has closed, but UTHR is being traded in the after-hours session. After-Hours quote »
160.24
Delayed Data
As of 3:59pm ET
 +0.77 / +0.48%
Today’s Change
90.40
Today|||52-Week Range
190.29
+23.75%
Year-to-Date

Today’s Trading

Previous close159.47
Today’s open162.22
Day’s range156.29 - 163.62
Volume421,887
Average volume (3 months)598,825
Market cap$7.3B
Dividend yield--
Data as of 3:59pm ET, 08/27/2015

Growth & Valuation

Earnings growth (last year)+91.46%
Earnings growth (this year)+13.59%
Earnings growth (next 5 years)+9.40%
Revenue growth (last year)+15.36%
P/E ratio48.9
Price/Sales5.44
Price/Book6.05

Competitors

 Today’s
change
Today’s
% change
MDVNMedivation Inc+2.36+2.63%
RCPTReceptos Inc-0.03-0.01%
IDXXIDEXX Laboratories I...+1.49+2.07%
OPKOPKO Health Inc-0.27-2.37%
Data as of 4:04pm ET, 08/27/2015

Financials

Next reporting dateOctober 29, 2015
EPS forecast (this quarter)$2.36
Annual revenue (last year)$1.3B
Annual profit (last year)$340.1M
Net profit margin26.39%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Co-Chief Executive Officer
Martine A. Rothblatt
President, Co-Chief Executive Officer &
Director
Roger A. Jeffs
Corporate headquarters
Silver Spring, Maryland

Forecasts

Partner Offers